Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
EXEL - TOTAL EQUITY
Total Equity EXEL - Exelixis, Inc.
2.26 B
LAST VALUE
1.20%
2 YEAR CAGR
11.95%
5 YEAR CAGR
42.36%
10 YEAR CAGR